tiprankstipranks
Coya Therapeutics Advances Pipeline for Neurodegenerative Diseases
PremiumCompany AnnouncementsCoya Therapeutics Advances Pipeline for Neurodegenerative Diseases
2M ago
Coya Therapeutics reports Q3 EPS (26c), consensus (41c)
Premium
The Fly
Coya Therapeutics reports Q3 EPS (26c), consensus (41c)
2M ago
Coya Therapeutics Announces Leadership Change and New CEO
Premium
Company Announcements
Coya Therapeutics Announces Leadership Change and New CEO
2M ago
Coya Therapeutics announces direct CNS anti-inflammatory effect of COYA 302
PremiumThe FlyCoya Therapeutics announces direct CNS anti-inflammatory effect of COYA 302
3M ago
Coya Therapeutics initiated with a Buy at H.C. Wainwright
Premium
The Fly
Coya Therapeutics initiated with a Buy at H.C. Wainwright
3M ago
Coya Therapeutics CEO Howard Berman to leave role, Arun Swaminathan to succeed
Premium
The Fly
Coya Therapeutics CEO Howard Berman to leave role, Arun Swaminathan to succeed
4M ago
Coya Therapeutics initiated with a Buy at Rodman & Renshaw
PremiumThe FlyCoya Therapeutics initiated with a Buy at Rodman & Renshaw
6M ago
Coya  publishes  ALS study in peer-reviewed Frontiers in Neurology
Premium
The Fly
Coya publishes ALS study in peer-reviewed Frontiers in Neurology
6M ago
Coya  completes of Phase 2 study of LD IL-2 to treat moderate AD
Premium
The Fly
Coya completes of Phase 2 study of LD IL-2 to treat moderate AD
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100